TELA Bio (TELA) Deferred Taxes (2025)
TELA Bio (TELA) posted Deferred Taxes of $7.2 million for Q4 2025, up 21809.09% on a QoQ basis from $33000.0 in Q2 2025.
Powered by 
Analysis
TELA Bio (TELA) Deferred Taxes (2025) Analysis & Trends
TELA Bio has reported Deferred Taxes for 1 years, with the latest figure at $7.2 million in Q4 2025.
- On a quarterly basis, Deferred Taxes changed N/A year-over-year to $7.2 million in Q4 2025; TTM through Dec 2025 was $7.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at $7.3 million, down 36.71% from the prior year.
- Deferred Taxes was $7.2 million for Q4 2025 at TELA Bio, up from $33000.0 in the prior quarter.
- The five-year high for Deferred Taxes was $7.2 million in Q4 2025, with the low at $33000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.74 Bn | 175.14 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.72 Bn | 122.50 Bn | 1.96 Bn | -31.00 Mn |
| 3 | Medtronic | 116.88 Bn | 108.06 Bn | 6.34 Bn | 127.00 Mn |
| 4 | Stryker | 104.10 Bn | 100.62 Bn | 4.50 Bn | 107.00 Mn |
| 5 | Boston Scientific | 63.74 Bn | 63.20 Bn | 3.85 Bn | 17.00 Mn |
| 6 | Edwards Lifesciences | 49.85 Bn | 45.60 Bn | 1.35 Bn | -181.30 Mn |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.15 Bn | 30.20 Bn | 830.00 Mn | -300,000.00 |
| 9 | Steris | 20.63 Bn | 20.15 Bn | 684.20 Mn | 600,000.00 |
| 10 | TELA Bio | 48.87 Mn | 18.44 Mn | 13.94 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 7.23 Mn |
| Jun 30, 2025 | 33,000.00 |
| Mar 31, 2025 | 52,000.00 |